Identical p53 Gene Mutation in Malignant Proliferating Trichilemmal Tumor of the Scalp and Small Cell Carcinoma of the Common Bile Duct: The Necessity for Therapeutic Caution

    Noboru Nakai, Hideya Takenaka, Shinshichi Hamada, S Kishimoto
    TLDR Identical p53 gene mutations in different cancers suggest the need for careful treatment.
    A 32-year-old man with a malignant proliferating trichilemmal tumour (MPTT) on his scalp underwent combination chemotherapy and radiation therapy, followed by surgical excision of the tumour and cervical lymph node dissection. Despite these treatments, he developed small cell carcinoma (SCC) of the common bile duct (CBD) and died one year later. Both the MPTT and SCC shared an identical p53 gene mutation, highlighting the necessity for therapeutic caution due to the potential for aggressive metastasis and secondary malignancies.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 7 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  828 upvotes 5 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Dermatologist told me to quit fin after turning 40

      in Finasteride/Dutasteride  194 upvotes 1 year ago
      A dermatologist advised a patient to stop taking finasteride (fin) after turning 40 due to potential risk of aggressive prostate cancer. The patient and others in the conversation debated this advice, discussing the relationship between finasteride, prostate cancer, and hair loss, and considering alternatives like topical finasteride.
      [object Object]

      community Hair Cloning, Trials were supposed to begin 2020-2021

      in Technology  48 upvotes 4 years ago
      The conversation discusses hair cloning trials expected to start in 2020-2021 and mentions concerns about potential delays due to the Coronavirus. Treatments like Minoxidil, finasteride, and RU58841 are referenced.

      community Oral vs Topical Finasteride for Trans Women

      in Transgender 5 months ago
      A user is using a Finoxidil topical spray and is curious if oral Finasteride would be more effective, considering they are already on a DHT blocker called Cyproterone. They are concerned about the potential impact of oral Finasteride on their transition.

      community Expectations control for SCUBE3

      in Research/Science  22 upvotes 10 months ago
      SCUBE3, a protein linked to hair growth in moles, was discovered over 25 years ago and is being developed by Amplifica for potential hair loss treatment. Concerns exist about SCUBE3's association with cancer, as it is a protein that promotes cell growth, which could potentially trigger cancer development if used for hair growth therapy.

      community 5% Minoxidil after 4 months - started with twice a day but went down to once because I kept forgetting in the morning. Really happy with how it is going!

      in Progress Pictures  438 upvotes 1 year ago
      The conclusion of the conversation is that the user started using 5% Minoxidil for hair loss and is happy with the progress. They also mentioned being trans and coming off testosterone, which they believe will help prevent further hair loss. Some users suggested using finasteride as well.

    Similar Research

    5 / 1000+ results